Two phase 3, randomized trials of inhaled treprostinil for idiopathic pulmonary fibrosis (IPF) were conducted on the basis of preclinical and clinical evidence of an antifibrotic mechanism.

For decades, many runners, and even coaches, have assumed that being a runner meant never walking during a training run or race. Even the most accomplished runners would apologize when they walked at ...